The present invention relates to improved and novel processes for the preparation of 2-{4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}- N-(methylsulfonyl) acetamide of formula-1, which is represented by the following structural formula:

Abstract The present invention relates to novel crystalline form of 2-{4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy} - N-(methylsulfonyl) acetamide compound of formula-1 and process for. the preparation thereof.

The present invention relates to an improved process for the preparation of N-[(4-fluorophenyl) methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxa diazol-2-yl)carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxamide monopotassium salt compound of formula-1a, which is represented by the following s...

The present invention relates to amorphous MTBE solvate of Tigecycline compound of formula-1 and process for preparation thereof.

The present application relates to an improved process for the preparation of 10 Ozanimod, its salts and intermediates thereof. which is represented by the following structural formula-1.

The present application relates to an improved and novel process for the preparation of docosanol, which is represented by the following structural formula-1. 5 Formula-1

The present invention relates to novel crystalline form of 2-{4-[(5,6-diphenylpyrazin-2- yl)(isopropyl)amino]butoxy}- N-(methylsulfonyl) acetamide compound of formula-1, which is represented by the following structural formula: Formula-1

The present application relates to a process for the preparation of Carbimazole, which 5 is represented by the following structural formula-1. Formula-1

The present invention relates to an improved process for the preparation of 2-chloro-5-(1-hydroxy-3-oxoisoindolin-1-yl)benzenesulfonamide compound of formula-1, which is represented by the following structural formula:                          Formula-1

The present invention relates to a crystalline form of 1-cyclopropyl-8-methyl-7-(5- methyl-6-(methylamino)pyridin-3-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid compound of formula-1, which is represented by the following structural formula. The present invention also relates to process for the preparation cr...

The present application relates to process for the preparation of Netarsudil dimesylate, its pharmaceutically acceptable salts, and intermediates thereof, which is represented by the following structural formula-I. 10 Formula-I

The present application relates to an improved process for the preparation of Divalproex sodium, which is represented by the following 10 structural formula-1. Formula-1

The present application relates to an improved and novel process for the preparation of Varenicline Tartrate, which is represented by the following 10 structural formula-1. Formula-1 15

TITLE OF THE INVENTION : A process for the preparation of Deutetrabenazine and 5 intermediates thereof. The present application relates to a process for the preparation of deutetrabenazine, and intermediates thereof; which is represented by the following structural formula-I.

Title of the invention : An improved process for the preparation of Besifloxacin 5 Hydrochloride and intermediates thereof. The present application relates to an improved process for the preparation of Besifloxacin hydrochloride and intermediates thereof, which is represented by the following structural formula-...

TITLE OF THE INVENTION : A process for the preparation of Ozanimod Hydrochloride and intermediates thereof; 10 The present application relates to a process for the preparation of Ozanimod Hydrochloride, and intermediates thereof. which is represented by the following structural formula-1a. 15 Formula-1a ...

Abstract 5 The present application relates to an improved process for the preparation of Penciclovir, and intermediates thereof; which is represented by the following structural formula-I. 10 Formula-I

Abstract The present application relates to an improved process 5 for the preparation of Lercanidipine Hydrochloride and intermediates thereof, which is represented by the following structural formula-1. 10 Formula-1

TITLE OF THE INVENTION: An improved process for the preparation of Levodopa. 10 The present application relates to an improved process for the preparation of Levodopa, which is represented by the following structural formula-I. 15 Formula-I

The present invention relates to a crystalline form of N-ethyl-1-(3-(trifluoro methyl) phenyl) propan-2-amine hydrochloride compound of formula-1, which is represented by the following structural formula. The present invention also relates to process for the preparation of compound of formula-1. 10 Formula-1 ...

TITLE OF THE INVENTION: A process for the preparation of Siponimod hemi fumaric acid and intermediates thereof 5 The present application relates to a process for the preparation of Siponimod hemi fumaric acid and intermediates thereof, which is represented by the following structural formula-I. ...

TITLE OF THE INVENTION : An efficient process for nicotinic receptor agonist, varenicline tartrate salt; 10 The present application relates to an improved process for the preparation of Varenicline tartrate free form nitroso impurities, which is represented by the following structural formula-1. 15 Formula-1 ...

TITLE OF THE INVENTION : A process for the preparation of raltegravir 10 potassium and its intermediates thereof. The present invention relates to a process for the preparation of N-[(4-fluorophenyl) methyl]-1,6-dihydro5- hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl) carbonyl] amino]ethyl]-6-...

TITLE OF THE INVENTION: Crystalline forms of Netarsudil dimesylate and process for preparation thereof; 10 The present application relates to polymorphs of Netarsudil dimesylate salt and process thereof, which is represented by the following structural formula-I. 15 Formula-I

TITLE OF THE INVENTION: A process for the preparation of 1,3-Dihydro-1-methyl- 2H-imidazole-2-thione The present application relates to a process for the preparation of Methimazole, which 10 is represented by the following structural formula-1. 15 Formula-1

TITLE OF THE INVENTION : A process for the preparation of Esketamine hydrochloride and intermediates thereof 10 The present application relates to a process for the preparation of Esketamine hydrochloride and intermediates thereof, which is represented by the following structural formula-I. 15 Formula-I. ...

TITLE OF THE INVENTION: 10 Polymorphs of 5-(3-{(1S)-1-[(2-hydroxyethyl)amino]-2,3-dihydro-1H-inden-4-yl}-1,2,4- oxadiazol-5-yl)-2[(propan-2-yl)oxy]benzonitrile Hydrochloride and process for preparation thereof. 15 The present invention relates to novel crystalline form of 5-(3-{(1S)-1-[(2- hydroxyethyl)amino]-2...

TITLE OF THE INVENTION: A process for preparation of finerenone and intermediates thereof. The present application relates to an improved process for the preparation of finerenone and intermediates thereof, which is represented by the following structural formula-I.

Abstract TITLE OF THE INVENTION: A process for preparation of Viloxazine Hydrochloride and intermediates thereof. The present application relates to an improved process for the preparation of Viloxazine Hydrochloride and its intermediate’s thereof, represented by the following structural formula-I. ...

Abstract TITLE OF THE INVENTION: A process for preparation of Ospemifene and intermediates thereof. The present application relates to an improved process for the preparation of Ospemifene, and intermediate’s thereof, represented by the following structural formula-I. Formul...

TITLE OF THE INVENTION : An improved process for Vonoprazan Fumarate and intermediates thereof The present application relates to an improved process for the preparation of Vonoprazan fumarate, and intermediates thereof, which is represented by the following structural formula-I. ...

Abstract TITLE OF THE INVENTION: An improved process for finerenone and intermediates thereof. The present application relates to an improved process for the preparation of finerenone and intermediates thereof, is represented by the following structural formula-I. ...

Abstract TITLE OF THE INVENTION : An improved process for Mitapivat sulfate and intermediates thereof; The present application relates to an improved process for the preparation of Mitapivat sulfate, and intermediates thereof, which is represented by the following structural formula-I. Formula-...

Abstract TITLE OF THE INVENTION: Polymorphs for Mitapivat sulfate and processes thereof The present application relates to novel crystalline forms for Mitapivat sulfate and processes thereof, is represented by the following structural formula-I.

Abstract TITLE OF THE INVENTION: An improved process for [(1R)-1-(2-Chlorophenyl)-2- (tetrazol-2-yl) ethyl] carbamate The present application relates to an improved process for the preparation of cenobamate, is represented by the following structural formula-I.

TITLE OF THE INVENTION: Process for 2-(1-Methylethyl)-5-[(1E)-2- phenyl ethenyl]-1,3-benzenediol and polymorphs thereof The present invention relates to process for 2-(1-Methylethyl)-5-[(1E)-2-phenyl ethenyl]-1,3-benzenediol and polymorphs and intermediates thereof, which is represented by the following str...

Abstract TITLE OF THE INVENTION: An improved process for (2R,3S)-2-[4-(Cyclopentyl amino) phenyl]-1-(2-fluoro-6-methylbenzoyl)-N-[4-methyl-3-(trifluoromethyl)phenyl]-3-piperidine carboxamide and intermediates thereof . The present application relates to an improved process for the preparation of avacopan a...

Abstract TITLE OF THE INVENTION: An improved process for methyl {4,6-diamino-2-[5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b] pyridin-3-yl] pyrimidin-5-yl} carbamate and intermediates thereof. The present application relates to an improved process for the preparation of vericiguat, which is represented by...

Abstract TITLE OF THE INVENTION: Crystalline form of Mitapivat sulfate hydrate and processes thereof The present application relates to crystalline form of Mitapivat sulfate hydrate and process thereof, is represented by the following structural formula-I.

Abstract TITLE OF THE INVENTION: An improved process for 3-(1-methylethyl)-6-[[(1S)-1-phenylethyl]amino]- 2,4(1H,3H)- pyrimidinedione and intermediates thereof The present invention relates to an improved process for preparation of 3-(1-methylethyl)-6-[[(1S)-1-phenylethyl]amino]- 2,4(1H,3H)- pyrimidinedio...

Abstract TITLE OF THE INVENTION: An improved process for N-((1s,3s)-3-(methyl(7H-pyrrolo [2,3-d]pyrimidin-4-yl)amino) cyclobutyl)propane-1-sulfonamide and intermediates thereof The present application relates to an improved process for abrocitinib and intermediates thereof, is represented by the following...

Abstract 5 TITLE OF THE INVENTION: An alternative process for (3R)-7-[[4-cyclopentyl-3-(trifluoro methyl) phenyl] methoxy]-1,2,3,4- tetra hydrocyclopent [b]indole-3-acetate, L-Arginine and intermediates thereof. 10 The present application relates to an alternative process for Etrasimod L-Arginine and intermedi...

Abstract TITLE OF THE INVENTION: An alternative process for (2S)-2-amino-3-[3-hydroxy-4-(phosphonooxy)phenyl] propanoic acid and intermediates thereof. The present application relates to an alternative process for (2S)-2-amino-3-[3-hydroxy-4-(phosphonooxy)phenyl] propanoic acid and intermediates thereof...

TITLE OF THE INVENTION: An improved process for (S)-7-((5, 7-difluorochroman-4-yl)oxy)-N,N,2-trimethyl-1H-benzo[d]imidazole-5-carboxamide and intermediates thereof The present application relates to an improved process for tegoprazan and intermediates thereof, represented by the following structural formula-I. ...